{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:57:32Z","timestamp":1649037452699},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:00:00Z","timestamp":1471996800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-1009-1","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T15:11:39Z","timestamp":1472051499000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Koki","family":"Ueda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Sukegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,24]]},"reference":[{"key":"1009_CR1","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","volume":"117","author":"SD Dojcinov","year":"2011","unstructured":"Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011;117:4726\u201335.","journal-title":"Blood"},{"key":"1009_CR2","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1038\/emm.2014.82","volume":"47","author":"CY Ok","year":"2015","unstructured":"Ok CY, Li L, Young KH. EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Exp Mol Med. 2015;47:e132.","journal-title":"Exp Mol Med"},{"key":"1009_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nri1201","volume":"3","author":"R Kuppers","year":"2003","unstructured":"Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol. 2003;3:801\u201312.","journal-title":"Nat Rev Immunol"},{"key":"1009_CR4","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460\u201371.","journal-title":"Lancet"},{"key":"1009_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00428-011-1186-7","volume":"460","author":"E Takahashi","year":"2012","unstructured":"Takahashi E, Kojima M, Kobayashi M, Kitamura A, Yokoi T, Hara K, et al. Primary IgG4-related lymphadenopathy with prominent granulomatous inflammation and reactivation of Epstein-Barr virus. Virchows Arch. 2012;460:225\u20139.","journal-title":"Virchows Arch"},{"key":"1009_CR6","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/PAS.0000000000000206","volume":"38","author":"M Takeuchi","year":"2014","unstructured":"Takeuchi M, Sato Y, Yasui H, Ozawa H, Ohno K, Takata K, et al. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease. Am J Surg Pathol. 2014;38:946\u201355.","journal-title":"Am J Surg Pathol"},{"key":"1009_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","volume":"99","author":"Y Shimoyama","year":"2008","unstructured":"Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008;99:1085\u201391.","journal-title":"Cancer Sci"},{"key":"1009_CR8","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009;20:1472\u201382.","journal-title":"Ann Oncol"},{"key":"1009_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","volume":"122","author":"CY Ok","year":"2013","unstructured":"Ok CY, Papathomas TG, Medeiros LJ, Young KH. EBV-positive diffuse large B-cell lymphoma of the elderly. Blood. 2013;122:328\u201340.","journal-title":"Blood"},{"key":"1009_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/PAP.0b013e3181ee63ce","volume":"17","author":"W Cheuk","year":"2010","unstructured":"Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17:303\u201332.","journal-title":"Adv Anat Pathol"},{"key":"1009_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","volume":"38","author":"SA Rezk","year":"2007","unstructured":"Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol. 2007;38:1293\u2013304.","journal-title":"Hum Pathol"},{"key":"1009_CR12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","volume":"85","author":"DM Knowles","year":"1995","unstructured":"Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552\u201365.","journal-title":"Blood"},{"key":"1009_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","volume":"126","author":"A Nicolae","year":"2015","unstructured":"Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, et al. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood. 2015;126:863\u201372.","journal-title":"Blood"},{"key":"1009_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00535-010-0221-9","volume":"45","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471\u20137.","journal-title":"J Gastroenterol"},{"key":"1009_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1009_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91:57\u201366.","journal-title":"Medicine"},{"key":"1009_CR17","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755\u201362.","journal-title":"Arthritis Rheum"},{"key":"1009_CR18","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","volume":"13","author":"T Oyama","year":"2007","unstructured":"Oyama T, Yamamoto K, Asano N, Oshiro A, Suzuki R, Kagami Y, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007;13:5124\u201332.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"1009_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/annonc\/5.suppl_1.S113","volume":"5","author":"D Rea","year":"1994","unstructured":"Rea D, Delecluse HJ, Hamilton-Dutoit SJ, Marelle L, Joab I, Edelman L, et al. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin\u2019s lymphomas. French Study Group of Pathology for HIV-associated Tumors. Ann Oncol. 1994;5 Suppl 1:113\u20136.","journal-title":"Ann Oncol"},{"key":"1009_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V90.1.313","volume":"90","author":"L Ometto","year":"1997","unstructured":"Ometto L, Menin C, Masiero S, Bonaldi L, Del Mistro A, Cattelan AM, et al. Molecular profile of Epstein-Barr virus in human immunodeficiency virus type 1-related lymphadenopathies and lymphomas. Blood. 1997;90:313\u201322.","journal-title":"Blood"},{"key":"1009_CR21","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117:5835\u201349.","journal-title":"Blood"},{"key":"1009_CR22","doi-asserted-by":"publisher","first-page":"e78730","DOI":"10.1371\/journal.pone.0078730","volume":"8","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Oda M, Kuroda Y, Katayama Y, Okikawa Y, Masunari T, et al. Clinical significance of sIL-2R levels in B-cell lymphomas. PLoS One. 2013;8:e78730.","journal-title":"PLoS One"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-016-1009-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1009-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:42:26Z","timestamp":1601041346000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-1009-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-1009-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,24]]},"article-number":"236"}}